{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:28:29Z","timestamp":1791912509891,"version":"4.3.4"},"reference-count":83,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"unspecified","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2021,5,4]]},"DOI":"10.1080\/13543784.2021.1897567","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:12:35Z","timestamp":1617253955000},"page":"483-493","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":71,"title":["Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody\u2013Positive Generalized Myasthenia Gravis"],"prefix":"10.1080","volume":"30","author":[{"suffix":"Jr.","given":"James F.","family":"Howard","sequence":"first","affiliation":[{"name":"Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils E.","family":"Gilhus","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen and Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiaki","family":"Utsugisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hanamaki General Hospital, Hanamaki, Iwate, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra W.","family":"Duda","sequence":"additional","affiliation":[{"name":"UCB Pharma, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Farzaneh-Far","sequence":"additional","affiliation":[{"name":"UCB Pharma, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Neurology, International University of Health and Welfare, Narita, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Translational Neurology, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20950"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.07.006"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26695"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013278"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-129"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-010-0285-6"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2015.01.022"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2019.15.3.376"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.9790\/0853-13756797"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs663"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2015.1030614"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60181-9"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.011"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31825644ff"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12310"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.26.11.1054"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.12.1246"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg223"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3381-14.2015"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.2393"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.6.1167"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.27.4.307"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13522"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S261414"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108327"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29894"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.05.006"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.4.1.43"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06783.x"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004923"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.4.1192.1192"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf151"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902814"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.06.007"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03019.x"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12217"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602489"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002790"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-44"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_452_17"},{"key":"cit0046","volume-title":"CADTH rapid response reports. Rituximab for the treatment of myasthenia gravis: a review of clinical effectiveness, cost-effectiveness, and guidelines","author":"Banerjee S","year":"2018"},{"key":"cit0047","doi-asserted-by":"crossref","first-page":"e2182","DOI":"10.1212\/WNL.0000000000005692","volume":"90","author":"Nowak RJ","year":"2018","journal-title":"Neurology"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0851"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26156"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004341"},{"key":"cit0051","unstructured":"Sinclair A, Nicolau I, Xie X, et al. The effectiveness and safety of rituximab (anti-CD20) in neurologic autoimmune diseases. Technology Assessment Unit (TAU) of the McGill University Health Centre (MUHC). 2013. [cited 2020 May 20]. Available from: https:\/\/secureweb.mcgill.ca\/tau\/sites\/mcgill.ca.tau\/files\/muhc_tau_2013_64_rituximab.pdf"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23839"},{"key":"cit0053","volume-title":"Soliris (eculizumab): summary of product characteristics","author":"European Medicines Agency","year":"2020"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1"},{"key":"cit0055","unstructured":"FDA approves Soliris (eculizumab) for the treatment of patients with generalized myasthenia gravis (gMG) [Internet]. 2017. [cited 2020 May 20]. Available from: https:\/\/ir.alexion.com\/news-releases\/news-release-details\/fda-approves-solirisr-eculizumab-treatment-patients-generalized"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0875-9"},{"key":"cit0057","volume-title":"Soliris (eculizumab): US prescribing information","author":"US Food and Drug Administration","year":"2019"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311084"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12180"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.030"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0400-0"},{"key":"cit0062","volume":"11","author":"New HR","year":"2020","journal-title":"Front Immunol"},{"key":"cit0063","first-page":"255","volume":"86","author":"Suh J","year":"2013","journal-title":"Yale J Biol Med"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-015-0298-1"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.5125"},{"key":"cit0066","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3324\/haematol.2016.146092","volume":"101","author":"Johnston J","year":"2016","journal-title":"Haematologica"},{"key":"cit0067","first-page":"247","volume":"101","author":"Johnston J","year":"2016","journal-title":"Haematologica"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00061.2007"},{"key":"cit0069","volume-title":"Presented at American Association of Neuromuscular & Electrodiagnostic Medicine, October 16\u201319","author":"Ricardo A","year":"2019"},{"key":"cit0070","unstructured":"Myasthenia Gravis Foundation of America. Myasthenia gravis: a manual for the health care provider. New York, NY: Myasthenia Gravis Foundation of America; 2009. [cited 2020 May 20]. Available from: https:\/\/myasthenia.org\/Portals\/0\/Provider%20Manual_ibook%20version.pdf."},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(00)01595-2"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb11015.x"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.7.1487"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23988"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22140"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25198"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dc1b1e"},{"key":"cit0078","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1212\/WNL.0000000000007887","volume":"93","author":"Howard JF Jr","year":"2019","journal-title":"Neurology"},{"key":"cit0079","unstructured":"US Food and Drug Administration. Search orphan drug designations and approvals: zilucoplan. [cited 2020 May 20]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=699319"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011207"},{"key":"cit0081","first-page":"135","volume":"60","author":"Howard JF Jr","year":"2019","journal-title":"Muscle Nerve"},{"key":"cit0082","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.26447","volume":"60","author":"Muppidi S","year":"2019","journal-title":"Muscle Nerve"},{"key":"cit0083","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.94.15_supplement.1494","volume":"94","author":"Wingerchuk DM","year":"2020","journal-title":"Neurology"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2021.1897567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T04:49:24Z","timestamp":1724734164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2021.1897567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,4]]}},"alternative-id":["10.1080\/13543784.2021.1897567"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2021.1897567","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}